| Market Cap | ₹44Cr |
| ROE | -2583.67% |
| P/E Ratio(TTM) | 20.28 |
| EPS(TTM) | 2.16 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 66.28 |
| Book Value | -0.06 |
| Debt to Equity | -48.02 |
| Face Value | 10 |
| Parent Organisation | Medinova Diagnostic Services Limited |
| Managing Director | Mr. K. Sunil Kondapall |
| BSE Symbol | 526301 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 48.09 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 69.16 | ||
| Metropolis Healthcare | NA (0.00%) | 63.88 | ||
| Thyrocare Technologies | NA (0.00%) | 58.36 |